[Neuroleptic malignant syndrome].
Dahm
J B
JB
Medizinische Klinik II, Paracelsusklinik Hemer.
Trenckmann
U
U
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000628:therapy; D010830:Physostigmine / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy*
D014150:Antipsychotic Agents; D010830:Physostigmine
Malignes neuroleptisches Syndrom.